Does BOTULINUM TOXIN TYPE A Cause Epilepsy? 639 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 639 reports of Epilepsy have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 17.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
639
Reports of Epilepsy with BOTULINUM TOXIN TYPE A
17.1%
of all BOTULINUM TOXIN TYPE A reports
511
Deaths
424
Hospitalizations
How Dangerous Is Epilepsy From BOTULINUM TOXIN TYPE A?
Of the 639 reports, 511 (80.0%) resulted in death, 424 (66.4%) required hospitalization, and 430 (67.3%) were considered life-threatening.
Is Epilepsy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 639 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Epilepsy?
LEVETIRACETAM (2,546)
LAMOTRIGINE (1,758)
ADALIMUMAB (1,107)
TOPIRAMATE (1,066)
METHOTREXATE (960)
LACOSAMIDE (902)
VALPROATE (878)
CARBAMAZEPINE (869)
RITUXIMAB (846)
CETIRIZINE (837)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Epilepsy Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE